Ulteriori informazioni
This is the second edition of a well-received book that reflects the state of the art in cancer medical therapies and their side-effects, including immunotherapy and chemotherapeutic drugs. All chapters have been fully updated to include all the latest progress in drug discovery such as targeted therapies for each cancer type. From issues such as preservation of fertility to antiemetic therapy the book provides a very comprehensive overview of the field. The book includes a new chapter on immuno-oncology drugs.
Organised by organ system, it lists the toxicity, side-effects and measures of prevention pertaining to each type of drug used in cancer therapy. The most dangerous side-effects are priority so as to alert the reader to their importance.
Designed for quick reference in the clinical setting this book is primarily aimed at established medical oncologists but will also appeal to junior doctors, trainees, pharmacistsand nurses.
Sommario
1. Drug Interactions and Pharmacogenetics.- 2. Breast Cancer.- 3. Lung Cancer.- 4. Gastrointestinal Cancer: Selection of Clinically Relevant Drug-Induced Toxicities Encountered in Gastrointestinal Cancer Treatment.- 5. Gynecologic Cancer.- 6. Side Effects of Medical Cancer Therapy in Genito-Urinary Malignancies.- 7. Central Nervous System.- 8. Myeloid Malignancies.- 9. Lymphoma.- 10. Multiple Myeloma.- 11. Dermatologic Side Effects of Systemic Targeted Anticancer Therapy.- 12. Immune Check Point Inhibition.- 13. Preservation of Fertility in the Cancer Patient.- 14. Cardiotoxicity.- 15. Bone Marrow Toxicity: Red Blood Cells.- 16. Bone Marrow Toxicity: White Blood Cells.- 17. Toxicity of Bone-Targeted Agents in Malignancy.- 18. State of the Art of Antiemetic Therapy.- 19. Side Effects of Nociceptive Cancer Pain Treatments in Adults.- 20. Totally Implanted Access Ports: Indications and Prevention of Complications.
Info autore
Mario Dicato, Hematology-Oncology Service at Luxembourg Medical Center, Luxembourg, and Head of the Research Laboratory of the Luxembourg Foundation for Research on Cancer and Blood Disorders. M. Dicato trained at Lausanne University, completed his postgraduate training at the Universities of Geneva, Switzerland, Pittsburgh and Yale, USA. He did his fellowship (subspecialty training) in hematology at the Massachusetts General Hospital, Boston and was Clinical and Research Fellow in Medicine at Harvard University, Boston, USA.He has published more than 250 papers and numerous book chapters, and is an editorial board member of several scientific journals.
Eric VanCutsem, MD, PhD, is professor at the University of Leuven and head of the division of Digestive Oncology at the University Hospitals Leuven, Belgium. He trained at the University of Leuven and spent part of his training in Lausanne, Bristol, San Antonio and Rotterdam. He published more than500 peer-reviewed articles. He is member of the Belgian Royal Academy of Medicine and president of the Belgian Foundation Against. He is/was a committee or board member of several international scientific organizations, including ESMO, ASCO, EORTC, UEG, ESDO, ENETS.
Riassunto
This is the second edition of a well-received book that reflects the state of the art in cancer medical therapies and their side-effects, including immunotherapy and chemotherapeutic drugs. All chapters have been fully updated to include all the latest progress in drug discovery such as targeted therapies for each cancer type. From issues such as preservation of fertility to antiemetic therapy the book provides a very comprehensive overview of the field. The book includes a new chapter on immuno-oncology drugs.
Organised by organ system, it lists the toxicity, side-effects and measures of prevention pertaining to each type of drug used in cancer therapy. The most dangerous side-effects are priority so as to alert the reader to their importance.
Designed for quick reference in the clinical setting this book is primarily aimed at established medical oncologists but will also appeal to junior doctors, trainees, pharmacistsand nurses.
